1-11 of 11
Authors: V. T. H. B. M. Smit
Save search
Sort by
Journal Article

LBA63Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy

PDF
C L Creutzberg and others
Annals of Oncology, Volume 30, Issue Supplement_5, October 2019, mdz394.060, https://doi.org/10.1093/annonc/mdz394.060
Published: 01 October 2019
Journal Article

31PTumor-infiltrating lymphocytes, tumor-associated macrophages and HLA class 1 expression in breast cancer patients treated with neoadjuvant chemotherapy with or without zoledronic acid: A sub study of the NEOZOTAC trial

PDF
A F de Groot and others
Annals of Oncology, Volume 28, Issue suppl_11, December 2017, mdx711.012, https://doi.org/10.1093/annonc/mdx711.012
Published: 11 December 2017
Journal Article

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

PDF
S M de Boer and others
Annals of Oncology, Volume 29, Issue 2, February 2018, Pages 424–430, https://doi.org/10.1093/annonc/mdx753
Published: 27 November 2017
Journal Article
EDITOR'S CHOICE

Practical guidance for mismatch repair-deficiency testing in endometrial cancer

PDF
E. Stelloo and others
Annals of Oncology, Volume 28, Issue 1, January 2017, Pages 96–102, https://doi.org/10.1093/annonc/mdw542
Published: 13 October 2016
Journal Article

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)

PDF
A. Charehbili and others
Annals of Oncology, Volume 25, Issue 5, May 2014, Pages 998–1004, https://doi.org/10.1093/annonc/mdu102
Published: 27 February 2014
Journal Article

Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer

PDF
T. J. A. Dekker and others
Annals of Oncology, Volume 24, Issue 12, December 2013, Pages 2994–2998, https://doi.org/10.1093/annonc/mdt400
Published: 10 October 2013
Journal Article

Reliability of core needle biopsy for determining ER and HER2 status in breast cancer

PDF
T. J. A. Dekker and others
Annals of Oncology, Volume 24, Issue 4, April 2013, Pages 931–937, https://doi.org/10.1093/annonc/mds599
Published: 04 December 2012
Journal Article

Expression of cell adhesion molecules and prognosis in breast cancer

PDF
S Saadatmand and others
British Journal of Surgery, Volume 100, Issue 2, January 2013, Pages 252–260, https://doi.org/10.1002/bjs.8980
Published: 22 November 2012
Journal Article

The prognostic role of TGF-β signaling pathway in breast cancer patients

PDF
E. M. de Kruijf and others
Annals of Oncology, Volume 24, Issue 2, February 2013, Pages 384–390, https://doi.org/10.1093/annonc/mds333
Published: 28 September 2012
Journal Article

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial

PDF
A. Huijbers and others
Annals of Oncology, Volume 24, Issue 1, January 2013, Pages 179–185, https://doi.org/10.1093/annonc/mds246
Published: 02 August 2012
Journal Article

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

PDF
V. T. H. B. M. Smit and others
Nucleic Acids Research, Volume 16, Issue 22, 25 November 1988, Page 10952, https://doi.org/10.1093/nar/16.22.10952
Published: 25 November 1988